» Articles » PMID: 36181774

The MDMX Acidic Domain Uses Allovalency to Bind Both P53 and MDMX

Overview
Journal J Mol Biol
Publisher Elsevier
Date 2022 Oct 1
PMID 36181774
Authors
Affiliations
Soon will be listed here.
Abstract

Autoinhibition of p53 binding to MDMX requires two short-linear motifs (SLiMs) containing adjacent tryptophan (WW) and tryptophan-phenylalanine (WF) residues. NMR spectroscopy was used to show the WW and WF motifs directly compete for the p53 binding site on MDMX and circular dichroism spectroscopy was used to show the WW motif becomes helical when it is bound to the p53 binding domain (p53BD) of MDMX. Binding studies using isothermal titration calorimetry showed the WW motif is a stronger inhibitor of p53 binding than the WF motif when they are both tethered to p53BD by the natural disordered linker. We also investigated how the WW and WF motifs interact with the DNA binding domain (DBD) of p53. Both motifs bind independently to similar sites on DBD that overlap the DNA binding site. Taken together our work defines a model for complex formation between MDMX and p53 where a pair of disordered SLiMs bind overlapping sites on both proteins.

Citing Articles

Genetic Variations in Gene Contribute to Renal Cell Carcinoma Susceptibility: A Genotype-Phenotype Correlation Study.

Chang S, Chang W, Shih H, Chang C, Wu H, Tsai C Cancers (Basel). 2025; 17(2).

PMID: 39857959 PMC: 11763691. DOI: 10.3390/cancers17020177.


Protein disorder and autoinhibition: The role of multivalency and effective concentration.

Fenton M, Gregory E, Daughdrill G Curr Opin Struct Biol. 2023; 83:102705.

PMID: 37778184 PMC: 10841074. DOI: 10.1016/j.sbi.2023.102705.


Short Linear Motifs in Colorectal Cancer Interactome and Tumorigenesis.

Fasano C, Grossi V, Forte G, Simone C Cells. 2022; 11(23).

PMID: 36496998 PMC: 9737320. DOI: 10.3390/cells11233739.

References
1.
Vise P, Baral B, Latos A, Daughdrill G . NMR chemical shift and relaxation measurements provide evidence for the coupled folding and binding of the p53 transactivation domain. Nucleic Acids Res. 2005; 33(7):2061-77. PMC: 1075921. DOI: 10.1093/nar/gki336. View

2.
Sharma R, Raduly Z, Miskei M, Fuxreiter M . Fuzzy complexes: Specific binding without complete folding. FEBS Lett. 2015; 589(19 Pt A):2533-42. DOI: 10.1016/j.febslet.2015.07.022. View

3.
Kjaergaard M, Glavina J, Chemes L . Predicting the effect of disordered linkers on effective concentrations and avidity with the "C calculator" app. Methods Enzymol. 2021; 647:145-171. DOI: 10.1016/bs.mie.2020.09.012. View

4.
Popowicz G, Czarna A, Holak T . Structure of the human Mdmx protein bound to the p53 tumor suppressor transactivation domain. Cell Cycle. 2008; 7(15):2441-3. DOI: 10.4161/cc.6365. View

5.
Mittag T, Orlicky S, Choy W, Tang X, Lin H, Sicheri F . Dynamic equilibrium engagement of a polyvalent ligand with a single-site receptor. Proc Natl Acad Sci U S A. 2008; 105(46):17772-7. PMC: 2582940. DOI: 10.1073/pnas.0809222105. View